ArticleAnnals of surgical oncology2026
Causal Inference and Prognostic Modeling in Colorectal Cancer through Integration of Computational Pathology and Mendelian Randomization.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- ASO Author Reflections: Bridging the Gut-Immune Axis and Histology: A Novel Computational Approach to Colorectal Cancer.Annals of surgical oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundWhile traditional pathology supports the diagnosis and staging of colorectal cancer (CRC), computational pathology provides novel prognostic insights. Mendelian randomization (MR) is effective in uncovering causal relationships in cancer research; however, studies that integrate MR with pathology to investigate gut microbiota (GM), immune cells, and CRC remain limited. MATERIALS AND
methodsWe analyzed whole-slide images from The Cancer Genome Atlas Colon Adenocarcinoma/Rectal Adenocarcinoma (TCGA-COAD/READ) datasets using ResNet-50 and CellProfiler to extract pathological features. MR analysis and mediation analyses were then performed to identify causal links between GM, immune cells, and CRC. Causal single-nucleotide polymorphisms (SNPs) were mapped to corresponding genes (microbiome-immune genes), and the expression levels of these genes were correlated with the extracted image features. Finally, a prognostic model was constructed using machine learning algorithms.
resultsWe identified 55 causal relationships, 6 mediating effects, and 15 microbiome-immune genes. Among the extracted pathological features, 21 were found to be associated with these microbiome-immune genes. The prognostic model developed in this study demonstrated accurate performance in predicting CRC prognosis.
conclusionsBy integrating MR with computational pathology, we elucidated the causal relationships among GM, immune cells, and CRC, and successfully constructed a prognostic prediction model. This work provides new targets for the precision treatment of CRC.
Indexed as
Identifiers
41454195What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.